Dissecting the therapeutic effects of anti-CTLA-4 and ADT in a murine hormone-sensitive prostate cancer

被引：10
|
作者：
Subudhi, Sumit Kumar
Montalvo-Ortiz, Welby
Scher, Howard I.
Allison, James Patrick
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, New York, NY 10021 USA
[3] Mem Sloan Ketterings Ludwig Ctr Canc Immunotherap, Howard Hughes Med Inst, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
    Small, Eric J.
    Tchekmedyian, N. Simon
    Rini, Brian I.
    Fong, Lawrence
    Lowy, Israel
    Allison, James P.
    CLINICAL CANCER RESEARCH, 2007, 13 (06) : 1810 - 1815
  • [2] Therapeutic use of anti-CTLA-4 antibodies
    Blank, Christian U.
    Enk, Alexander
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 3 - 10
  • [3] Hormone-sensitive prostate cancer
    Ohlmann, Carsten
    UROLOGIE, 2023, 62 (04): : 345 - 346
  • [4] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [5] Anti-tumoral effects of novel lymphatic delivery of anti-CTLA-4 in a metastatic murine breast cancer model
    Kwon, Sunkuk
    Velasquez, Fred Christian
    Ross, Russel F.
    Hwu, Wen-Jen
    Sevick-Muraca, Eva M.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Efficacy and Safety of Enzalutamide Plus ADT Versus Placebo Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer: The Arches Trial
    Stenzl, A.
    Azad, A.
    Krivoshik, A.
    Baron, B.
    Hirmand, M.
    Armstrong, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 73 - 73
  • [7] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Singh, Kirti
    Mandal, Swarnendu
    Nayak, Prasant
    Das, Manoj
    Tripathy, Sambit
    LANCET ONCOLOGY, 2022, 23 (11): : E490 - E490
  • [8] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [9] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [10] Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape
    Hall, Mary E.
    Huelster, Heather L.
    Luckenbaugh, Amy N.
    Laviana, Aaron A.
    Keegan, Kirk A.
    Klaassen, Zachary
    Moses, Kelvin A.
    Wallis, Christopher J. D.
    ONCOTARGETS AND THERAPY, 2020, 13 : 3571 - 3581
12345